C. Brennan

Nature · 2004–2020

A researcher in the Science corpus: 19 papers; trusts 0 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Who trusts C. Brennan

1. J. Joyce (in Immunology)

Papers from C. Brennan's perspective

Ordered by how strongly the researchers C. Brennan trusts endorse each paper. Same corpus, a different order for every researcher.

1. Solution Hybrid Selection with Ultra-long Oligonucleotides for Massively Parallel Targeted Sequencing (Nature Biotechnology)
2. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers (Genome Biology)
3. Genetic pathways to primary and secondary glioblastoma. (American Journal of Pathology)
4. Human protein reference database—2006 update (Nucleic Acids Res.)
5. The biology of ovarian cancer: new opportunities for translation (Nature Reviews. Cancer)
6. The emerging roles of forkhead box (Fox) proteins in cancer (Nature Reviews. Cancer)
7. Malignant astrocytic glioma: genetics, biology, and paths to treatment. (Genes & Development)
8. A Landscape of Driver Mutations in Melanoma (Cell)
9. Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome (Clinical Cancer Research)
10. ARID1A mutations in endometriosis-associated ovarian carcinomas. (New England Journal of Medicine)

Their papers

• Malignant astrocytic glioma: genetics, biology, and paths to treatment. (2007) — 2,428 citations
• An integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR and NF1 (2010) — 7,152 citations
• An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells (2013) — 1,105 citations
• Integrated Genomic Analyses of Ovarian Carcinoma (2011) — 7,559 citations
• Comprehensive genomic characterization defines human glioblastoma genes and core pathways (2008) — 7,050 citations
• Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. (2006) — 602 citations
• Coactivation of Receptor Tyrosine Kinases Affects the Response of Tumor Cells to Targeted Therapies (2007) — 962 citations
• PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells (2009) — 827 citations
• Identification of DOK family genes as lung tumor suppressors (2010) — 122 citations
• Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells (2020) — 850 citations
• Tumor mutational load predicts survival after immunotherapy across multiple cancer types (2019) — 3,368 citations
• Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas (2015) — 2,738 citations
• Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO (2013) — 832 citations
• CSF-1R inhibition alters macrophage polarization and blocks glioma progression (2013) — 2,206 citations
• The Somatic Genomic Landscape of Glioblastoma (2013) — 4,593 citations
• A Brain Tumor Molecular Imaging Strategy Using A New Triple-Modality MRI-Photoacoustic-Raman Nanoparticle (2012) — 994 citations
• Glioblastoma stem-like cells give rise to tumour endothelium (2010) — 1,252 citations
• MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib (2007) — 1,698 citations
• Molecular characterization of the tumor microenvironment in breast cancer. (2004) — 1,266 citations